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Abstract
Background: Although metastasis of clear cell renal cell carcinoma (ccRCC) is basically observed in late stage tumors, T1
stage metastasis of ccRCC can also be found with no definite molecular cause resulting inappropriate selection of surgery
method and poor prognosis. Notch signaling is a conserved, widely expressed signal pathway that mediates various cellular
processes in normal development and tumorigenesis. This study aims to explore the potential role and mechanism of Notch
signaling in the metastasis of T1 stage ccRCC.
Methodology/Principal Findings: The expression of Notch1 and Jagged1 were analyzed in tumor tissues and matched
normal adjacent tissues obtained from 51 ccRCC patients. Compared to non-tumor tissues, Notch1 and Jagged1 expression
was significantly elevated both in mRNA and protein levels in tumors. Tissue samples of localized and metastatic tumors
were divided into three groups based on their tumor stages and the relative mRNA expression of Notch1 and Jagged1 were
analyzed. Compared to localized tumors, Notch1 expression was significantly elevated in metastatic tumors in T1 stage
while Jagged1 expression was not statistically different between localized and metastatic tumors of all stages. The average
size of metastatic tumors was significantly larger than localized tumors in T1 stage ccRCC and the elevated expression of
Notch1 was significantly positive correlated with the tumor diameter. The functional significance of Notch signaling was
studied by transfection of 786-O, Caki-1 and HKC cell lines with full-length expression plasmids of Notch1 and Jagged1.
Compared to the corresponding controls, all cell lines demonstrated significant promotion in cell proliferation and
migration while cell cycle remained unaffected.
Conclusions/Significance: High-level expression of Notch signaling increased the risk of metastasis in T1 stage ccRCC by
stimulating the proliferation and migration of tumor cells, which may be helpful for the selection of suitable operation
method and prognosis of ccRCC.
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Introduction
Renal cell carcinoma (RCC) is the second leading cause of
death among urologic tumors, accounting for 2% of adult
malignancies and the most common histologic subtype is clear
cell renal cell carcinoma (ccRCC) [1]. Generally, for T1 stage
kidney tumor, partial nephrectomy is the recommended surgery
for localized RCC and radical nephrectomy is needed for
metastatic tumors [2,3]. However, aside from the imaging
evidence, there is no definite molecular targets that can be used
to identify the metastatic liability of ccRCC which may help the
doctors to determine the suitable operation method in surgery.
In vertebrates there are four Notch genes (Notch1, Notch2,
Notch3 and Notch4), which encode receptors for at least five
different DSL Notch ligands (Jagged1/Serrate1, Jagged2/Ser-
rate2, Delta1, Delta3 and Delta4). The Notch proteins comprise a
conserved, widely expressed family of cell-surface receptors that
mediate various cellular processes including differentiation,
proliferation, and apoptosis via direct cell-cell interactions [4].
Interestingly, in the development of cancer, Notch may act as
either an oncogene or a tumor suppressor gene depending on the
tumor type [5].
So far, the mechanism of metastasis in T1 stage ccRCC was
poorly understood and there was a contradiction about the
expression and function of Notch1 in RCC in two different studies
[6,7], which led us to explore the effect of Notch signaling in the
metastasis of early stage ccRCC.
The overall aim of this study was to determine the potential role
and mechanism of Notch1 and Jagged1 in the metastasis of T1
stage renal tumors and our data showed that high-level expression
of Notch signaling increased the risk of metastasis in T1 stage
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35022ccRCC by stimulating the proliferation and migration of tumor
cells.
Materials and Methods
Ethics Statement
Prior written informed consent was obtained from all patients
and the study was approved by the Chinese People’s Liberation
Army General Hospital’s Protection of Human Subjects Commit-
tee.
Patients and tissue samples
51 ccRCC tissue samples including 25 metastatic tumor
samples, 26 localized tumor samples and adjacent non-tumorous
kidney tissue counterparts used for real-time RT-PCR and
Western-blot were collected at Chinese People’s Liberation Army
General Hospital (Beijing, China). The hard and firm tumor
tissues were trimmed free of normal tissue and snap frozen in
liquid nitrogen immediately after resection according to the
specimen regulation of PLA General Hospital. All RCC cases
were clinically and pathologically confirmed to be clear-cell
carcinoma and were staged based on the 2011 Union for
International Cancer Control (UICC) TNM classification of
malignant tumors (Table S1).
Cell culture and reagents
Human renal proximal tubular epithelial cell line HKC [8],
kidney tumor cell line 786-O [9] and Caki-1 [10] were cultured in
complete Dulbecco’s modified Eagle’s medium (Invitrogen,
Carlsbad, CA) with 10% fetal bovine serum (Invitrogen), 50 U/
ml of penicillin and 50 lg/ml of streptomycin (Invitrogen). All cells
were cultured in a sterile incubator maintained at 37uC with 5%
CO2.
RNA isolation and real-time RT-PCR
Total RNA was extracted using the PARIS
TM Kit (Applied
Biosystems, Foster City, CA) according to the manufacturer’s
protocol. Multiscribe
TM Reverse Transcriptase (Applied Biosys-
tems) was used to synthesize the complementary DNA templates.
Real-time reverse transcription–polymerase chain reactions were
performed in an Applied Biosystems 7500 Detection system using
MaximaH SYBR Green/ROX qPCR Master Mix Assays
(Fermentas, USA). The expression of mRNA was determined
from the threshold cycle (Ct), and the relative expression levels
were normalized to the expression of human peptidylprolyl
isomerase A (PPIA) mRNA [11] and calculated by the 2
2DDCt
method [12]. Primers used in real-time RT-PCR were listed in
Table 1.
Protein extraction and Western-blot analysis
Western blot analysis were carried out as described previously
[13]. Protein levels were quantified by Bradford assay. 30 mg
protein from each sample was fractionated by 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis and transferred
onto polyvinylidene fluoride membranes (PVDF membranes,
Millipore). The membrane was blocked in 0.1% Triton X-100
and 5% low fat milk powder in phosphate-buffered saline for
1 hour at 4uC and then probed with anti-glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (1:500; Santa Cruz Biotech-
nology, Santa Cruz, CA) rabbit polyclonal primary antibody, anti-
Notch1 (1:500, Abcam, Cambridge, MA) rabbit polyclonal
primary antibody, anti-Jagged1 (1:500, Santa Cruz Biotechnology)
rabbit polyclonal primary antibody. After washing 3 times with
Tris-buffered saline Tween-20, the membrane was incubated in
peroxidase-conjugated goat anti-mouse/rabbit IgG antibody
(1:1000, Santa Cruz Biotechnology). Bands were visualized by
an enhanced chemiluminescence detection system using medical
X-ray films and quantified by Photoshop (Adobe software). The
intensities of band of interest were expressed relative to the
GAPDH intensities from the same sample.
Plasmid transfection
2610
5 per well cells were seeded into 60 mm plates 24 hours
prior to plasmid transfection. Cells were then transfected with the
empty vector (pCMV6-Entry, catalogue No. PS100001, Origene,
Rockville, MD), or the human cDNA ORF clone of Notch1
(pCMV6-Notch1, catalogue No. RC211365) and Jagged1
(pCMV6-Jagged1, catalogue No. RC210516) using MegaTran
1.0 (Origene) for 6 hours in OptiMEM I Reduced Serum9
Medium (Invitrogen). Cells were harvested at the indicated time
points.
Cell growth analysis by MTS assay
To assess proliferation, cells were transfected with plasmids as
indicated above, 1610
3 cells were seeded into 96-well plates in
100 mL of 10% FBS/DMEM and cultured at 37uC in a 5% CO2
incubator. After culturing for 24, 48, 72, or 96 hours, 20 mL of the
CellTiter 96 Aqueous One Solution (Promega, Madison, WI) was
added to each well and then incubated for 1 hour at 37uCi na5 %
CO2 incubator. Absorbance was measured at 490 nm using a
microplate reader.
Cell migration analysis by transwell assay
Cell migration assay was carried out using Boyden chambers
containing Transwell (Corning Costar Corp., Cambridge, MA)
membrane filter inserts with pore size of 8 mm. Cells were
transfected with plasmids as indicated above. 3610
4 cells were
then seeded on Boyden chambers (upper chamber) in 150 ml
DMEM containing 0.2% BSA. The lower chambers were filled
Table 1. Real-time RT-PCR Primers.
Gene Primer Sequence Amplicon
Notch1 Forward primer: TGCCAGACCAACATCAAC (18 bp) 192 bp
Reverse primer: CTCATAGTCCTCGGATTGC (19 bp)
Jagged1 Forward primer: CCGTTGCTGACTTAGAAT (18 bp) 83 bp
Reverse primer: AGCCAACCACAGAAACTA (19 bp)
MMP-9 Forward primer: CCTGGAGACCTGAGAACCAATC
(22 bp)
80 bp
Reverse primer: CCACCCGAGTGTAACCATAGC
(21 bp)
P21 Forward primer: CGCTAATGGCGGGCTG (16 bp) 60 bp
Reverse primer: CGGTGACAAAGTCGAAGTTCC
(21 bp)
P27 Forward primer: CGCCATATTGGGCCACTAA (19 bp) 89 bp
Reverse primer: CGCAGAGCCGTGAGCAA (17 bp)
PPIA Forward primer: ATGGTCAACCCCACCGTGT (19 bp) 101 bp
Reverse primer: TCTGCTGTCTTTGGGACCTTGTC
(23 bp)
doi:10.1371/journal.pone.0035022.t001
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37uC, cells were stained with crystal violet and counted under a
microscope in 5 predetermined fields at 6100 by Photoshop
(Adobe software).
Cell cycle analysis by flow cytometry
48 hours after transfection with plasmids as indicated above,
cells were collected, fixed by 70% ethanol for 30 minutes and then
washed with ice-cold PBS. For the detection of cell cycle, cell
pellets were re-suspended in RNase-containing (1:100 in dilution)
PBS buffer on ice and stained with propidium iodide (PI) (BD
Biosciences, San Jose, CA) according to the manufacturer’s
protocol. Stained cells were analyzed on the FACS-Calibur (BD
Biosciences). Data were analyzed using the Cellquest Pro software
(BD Biosciences).
Statistics
When appropriate, two group comparisons were analyzed with
a t-test, multiple group comparisons were analyzed with a
Dunnett-test, and P values were calculated. P,0.05 was
considered significant.
Results
Elevated expression of Notch1 and Jagged1 in ccRCC
In order to determine the expression level of Notch1 and
Jagged1, 51 ccRCC samples including 25 metastatic tumor
samples, 26 localized tumor samples and adjacent non-tumorous
kidney tissue counterparts were used for real-time RT-PCR and
Western-blot.
After RNA isolation, we performed real-time RT-PCR to
measure the mRNA expression level of Notch1 and Jagged1. We
found out that Notch1 and Jagged1 expression was significantly
elevated in both localized and metastatic tumor tissues compared
to non-tumor tissues. Meanwhile Notch1 expression was higher in
metastatic tumors but Jagged1 expression was lower compared to
localized tumors indicating that the receptor and ligand of Notch
signaling may function differently in the metastasis of ccRCC
(Figure 1A).
Furthermore, we tested the protein expression in ccRCC
samples using western-blot assay. Similar to the mRNA expression
level, elevated expression of Notch1 and Jagged1 protein was
observed in tumor tissues compared to non-tumor tissues and
higher and lower expression of Notch1 and Jagged1 were detected
respectively in metastatic tumors compared to localized tumors
(Figure 1B).
High-level expression of Notch1 was associated with
metastasis of ccRCC at T1 stage
Based on our clinical experiences and several reports, ccRCC
metastasis were sometimes found at T1 or T2 stage [14]. So we
next intended to explore the relationship of Notch signaling in the
metastasis of early stage ccRCC.
Tissue samples of localized and metastatic tumors were divided
into three groups based on their tumor stages and the relative
mRNA expression of Notch1 and Jagged1 were analyzed. As
shown in Figure 2A, Notch1 expression was elevated in all stages
in metastatic tumors compared to localized tumors but the
difference was significant in T1 stage only (P=0.001). As for
Jagged1, the expression level had no statistically significant
difference in all three stages (Figure 2B). The results indicated
that only the receptor Notch1 was associated with the metastasis of
ccRCC at T1 stage.
Larger tumor size was a risk factor of metastasis of T1
stage ccRCC and correlated with the elevation of Notch1
expression
Renal tumor size has been reported by groups from multiple
institutions to be significantly associated with the risk of
synchronous and asynchronous metastasis [15,16]. So next we
analyzed the tumor diameter of localized and metastatic tumors in
T1 stage to find out whether larger tumor size could be a risk
factor for metastasis of early stage ccRCC. As shown in Figure 3A,
the average size of metastatic tumors was 6.37560.479 cm (n=4)
in diameter which was larger than localized tumors
(4.08961.237 cm, n=19, P=0.025). Furthermore, in order to
determine whether Notch signaling was relevant to the tumor size,
we analyzed the correlation of Notch1 and Jagged1 expression and
tumor diameter in T1 stage ccRCC. As shown in Figure 3B and
3C, Notch1 expression was positive correlated with tumor
diameter (n=23, R=0.435, P=0.038) while Jagged1 expression
was not significantly correlated with tumor size (n=23,
R=20.172, P=0.432).
Forced expression of Notch1 and Jagged1 stimulated the
proliferation of tumor cell
Since the tumor size was mainly determined by the growth
ability of tumor cells and Notch1 expression was positive
correlated with tumor size in T1 stage, we next intended to verify
whether larger tumor size which was observed in metastatic
ccRCC was a result of high-level expression of Notch signaling.
After transfecting Caki-1, 786-O and HKC cell lines with
pCMV6-Notch1, pCMV6-Jagged1 and pCMV6-Entry as indicat-
ed above, we examined the cell proliferation by MTS assay.
As shown in Figure 4, forced expression of Notch1 and Jagged1
promoted the growth of Caki-1 and 786-O cell line. For HKC cell
line, over expression of Notch1 also stimulated the growth ability
but there was no significant change on cell proliferation when
transfected with Jagged1 plasmid. The results showed that aside
from maintaining the growth of normal kidney cells, Notch1 could
also stimulate the growth of tumor cells which may facilitate the
progression of early stage ccRCC.
Forced expression of Notch1 and Jagged1 promoted the
migration of tumor cell
Elevated cell migration is an important mechanism that is
thought to increase metastatic potential of cancer cells. This
maybe independent of cell proliferation rates. Therefore, we
studied the effect of Notch1 and Jagged1 on cell migration of 786-
O and Caki-1 cell lines using the Boyden chamber transwell assay.
For 786-O cell line, after transfected with pCMV6-Notch1,
pCMV6-Jagged1 and pCMV6-Entry, the number of cells that
migrated through the Transwell membrane was 112.8612.7,
106.6612.7, and 53.666.0 (P=0.002 and P=0.003, respectively,
Figure 5A–C,G). For Caki-1 cell line, the number of cells that
migrated through the Transwell membrane was 93.869.3 for
Notch1 expression cells, 111.667.4 for Jagged1 expression cells,
and 52.665.9 for control cells (P=0.002 and P=0.000,
respectively, Figure 5D–F). To further verify the pro-metastatic
function of Notch signaling, we next examined the expression
change of MMP-9 which is a known metastasis gene [17] after
forced expression of Notch1 and Jagged1. As shown in Figure 5H,
the mRNA expression of MMP-9 was significantly elevated in
both 786-O and Caki-1 cell lines after over-expression of Notch1
and Jagged1. Taken together, the results indicated that high-level
expression of Notch signaling may contribute to the metastasis of
ccRCC by promoting the migration ability of tumor cells.
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35022Figure 1. Notch1 and Jagged1 expression in ccRCC tissues. (A) mRNA expression detected by real-time RT-PCR showing elevated Notch1
mRNA expression in localized and metastatic tumors compared to non-tumor(NT) tissues (P=0.001 and P=0.000 respectively), and higher expression
in metastatic tumors compared to localized tumors (P=0.028); On the right panel, analysis showing elevated Jagged1 mRNA expression in tumors
compared to NT (P=0.000 and P=0.000 for localized and metastatic tumors respectively), but lower expression in metastatic tumors compared to
localized tumors (P=0.005). Each dot representing a tissue sample. (B) Protein expression detected by western-blot assay showing elevated
expression of Notch1 and Jagged1 protein in tumor tissues compared to non-tumor tissues. The right panel was the densitometric analysis of the
bands. The data shown are mean6SD.
doi:10.1371/journal.pone.0035022.g001
Figure 2. Notch1 and Jagged1 mRNA expression analysis at different stages in ccRCC samples. (A) Analysis showing significantly higher
expression of Notch1 in metastatic tumors at T1 stage compared to localized tumors(P=0.001). (B) No statistically significant difference of Jagged1
expression in all three stages. The data shown are mean6SD.
doi:10.1371/journal.pone.0035022.g002
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tumor cell
To determine whether high-level expression of Notch signaling
could induce cell cycle alteration, we ectopic expressed pCMV6-
Notch1, pCMV6-Jagged1 and pCMV6-Entry in 786-O, Caki-1
and HKC cell lines and detected the cell cycle by flow cytometry.
As shown in Figure 6A–B, over expression of Notch1 and Jagged1
did not lead to significant change of cell cycle in all cell lines.
Furthermore, we examined the expression of P21 and P27 to
verify the negative affection on cell cycle. As shown in Figure 6C,
both P21 and P27 mRNA expression remained unchanged after
over-expression of Notch1 and Jagged1 indicating that the pro-
metastatic effect of Notch signaling may not function through the
regulation of cell cycle in ccRCC.
Discussion
Metastasis, the spread of tumor cells from the site of origin to
distant organs, has long been recognized as the major threat to the
survival of cancer patients [18,19]. Localized T1 stage ccRCC is
recommended for partial nephrectomy [3], however, distant
metastasis after the surgery was detected occasionally resulting a
second operation to remove the kidney and poor prognosis of the
patient. So far, the mechanism of metastasis was poorly
understood [20], thus it is imperative to find effective molecular
targets for the diagnosis and prevention of early stage kidney
cancer metastasis.
Although Notch1 has been reported to be pro-metastatic in
multiple cancers [21–25], the exact role of Notch signaling in
kidney cancer is not clear yet, so we intended to explore the
function of Notch signaling in the metastasis of ccRCC. First, we
studied the basic expression level of Notch1 and Jagged1 in 25
metastatic tumors, 26 localized tumors and adjacent non-
tumorous kidney tissue counterparts. Compared to non-tumor
tissues, Notch1 and Jagged1 expression were significantly elevated
both in mRNA and protein levels in localized and metastatic
tumors which was consistent with some other reports [6,26].
However, some investigators had also given opposite results that
the expression of Notch receptors was down-regulated and Notch
signaling might function as a tumor suppressor in the progress of
RCC [7]. Since Notch signaling is such a complicated and
comprehensive pathway, the underlying detailed mechanism of
this contradictory requires further study including an extensive
and complete study of all the receptors, ligands and even
downstream target genes.
Next we analyzed the mRNA expression of Notch1 and Jagged1
on different tumor stages of ccRCC. Compared to localized
tumors, Notch1 expression was significantly elevated in metastatic
Figure 3. Analysis of tumor diameter and Notch1 and Jagged1 mRNA expression level in T1 stage ccRCC. (A) Analysis showing larger
average diameter in metastatic tumors (6.37560.479 cm n=4) compared to localized tumors (4.08961.237 cm, n=19, P=0.025). (B) Positive
correlation of Notch1 expression and tumor diameter in T1 stage(n=23, R=0.435, P=0.038). (C) No correlation of Jagged1 expression and tumor size
in T1 stage(n=23, R=20.172, P=0.432). The data shown are mean6SD.
doi:10.1371/journal.pone.0035022.g003
Figure 4. Notch1 promoting the proliferation in tumor and normal kidney cell lines. Proliferation assay by MTS showing increased
proliferation in Caki-1 and 786-O cell line after Notch1 and Jagged1 expression. MTS assay in HKC cell line showing increased proliferation rate in
Notch1 expressing cells only. The data shown are means6SD from two independent experiments, each carried out in triplicate.
doi:10.1371/journal.pone.0035022.g004
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statistically different among all stages indicating that only the
receptor Notch1 was associated with the metastasis of ccRCC at
T1 stage.
Since tumor size had been reported to be a risk factor in the
metastasis of T1 stage RCC [27,28], we analyzed the correlation
of tumor size and relative mRNA expression of Notch1 and
Jagged1 in 23 T1 stage ccRCC samples. Notch1 expression was
positive correlated with tumor diameter while Jagged1 expression
had no significantly correlation with tumor size.
Taken together, we postulated that Notch1 may stimulate the
growth of tumor cells resulting larger tumor size and finally
metastasis of early stage ccRCC.
In order to verify our postulation, we transfected tumor cell lines
with Notch1 plasmid and examined the alteration of tumor cell
proliferation. As expected, the growth ability was significantly
enhanced after transfection indicating that elevated proliferation
by Notch1 was indeed a pivotal element of metastasis in early stage
tumor. Aside from the growth promoting function, we further
discovered Notch1 could also stimulate the migration of tumor
cells which will definitely facilitate the metastasis of kidney tumors.
Similar to Notch1, forced expression of Jagged1 also stimulated
the proliferation and migration of tumor cells. Because of the
function of Jagged1 which could enable the metastasis of ccRCC,
it is hard to understand the difference between Jagged1 and
Notch1 such as relative lower expression of Jagged1 in metastatic
tumors compared to localized tumors. The inconsistence of
expression level and function of Jagged1 may be attributed to
the complexity of regulatory mechanism in vivo [29]. Further
study is needed in the future to explicit the mechanism including
interaction between the receptor and ligand and potential
regulator of Notch signaling.
In conclusion, high-level expression of Notch signaling is
associated with the metastasis of T1 stage ccRCC by stimulating
Figure 5. Notch1 and Jagged1 promoting the migration in tumor cell lines. (A)–(C) are representative view of 786-O cell line transfected
with Notch1, Jagged1 and control plasmid respectively. (D)–(F) are Caki-1 cell line transfected with Notch1, Jagged1 and control plasmid respectively.
(G) Notch1 and Jagged1 can promote the migration of 786-O and Caki-1 tumor cell lines compared to the controls. (H) MMP-9 mRNA expression was
significantly elevated in Caki-1 and 786-O cell lines after transfected with Notch1 and Jagged1 plasmid. The data shown are mean6SD.
doi:10.1371/journal.pone.0035022.g005
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angle for the treatment and prevention of kidney cancer in clinic.
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